Identification of Candida albicans and Candida glabrata within 1.5 Hours Directly from Positive Blood Culture Bottles with a Shortened Peptide Nucleic Acid Fluorescence In Situ Hybridization Protocol

被引:26
作者
Gherna, Michael [1 ]
Merz, William G. [1 ]
机构
[1] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA
关键词
CHROMAGAR CANDIDA;
D O I
10.1128/JCM.01241-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Candida albicans and Candida glabrata can be identified in blood culture bottles within 2.5 h using peptide nucleic acid fluorescence in situ hybridization. A 1.25-h protocol was compared to the standard with 40 positive (clinical and spiked) blood culture bottles tested in batches of 5. All C. albicans (15) and C. glabrata (16) isolates, alone or mixed, were identified correctly using both protocols, whereas 18 isolates (five other species) were negative by both protocols. This shortened method will significantly reduce the time to identification.
引用
收藏
页码:247 / 248
页数:2
相关论文
共 10 条
  • [1] Treatment of severe Candida infections in high-risk patients in Germany:: Consensus formed by a panel of interdisciplinary investigators
    Büchner, T
    Fegeler, W
    Bernhardt, H
    Brockmeyer, N
    Duswald, KH
    Herrmann, M
    Heuser, D
    Jehn, U
    Just-Nübling, G
    Karthaus, M
    Maschmeyer, G
    Müller, FM
    Müller, J
    Ritter, J
    Roos, N
    Ruhnke, M
    Schmalreck, A
    Schwarze, R
    Schwesinger, G
    Silling, G
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2002, 21 (05) : 337 - 352
  • [2] Use of a commercial reagent leads to reduced germ tube production by Candida dubliniensis
    Davis, LE
    Shields, CE
    Merz, WG
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (05) : 2465 - 2466
  • [4] Yeast identification in the clinical microbiology accepted 15 August 2000 laboratory: phenotypical methods
    Freydiere, AM
    Guinet, R
    Boiron, P
    [J]. MEDICAL MYCOLOGY, 2001, 39 (01) : 9 - 33
  • [5] Hazen KC, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1762
  • [6] CHROMAGAR CANDIDA, A NEW DIFFERENTIAL ISOLATION MEDIUM FOR PRESUMPTIVE IDENTIFICATION OF CLINICALLY IMPORTANT CANDIDA SPECIES
    ODDS, FC
    BERNAERTS, R
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (08) : 1923 - 1929
  • [7] Results from the ARTEMIS DISK global antifungal surveillance study:: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing
    Pfaller, MA
    Diekema, DJ
    Rinaldi, MG
    Barnes, R
    Hu, B
    Veselov, AV
    Tiraboschi, N
    Nagy, E
    Gibbs, DL
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (12) : 5848 - 5859
  • [8] Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata
    Pfaller, MA
    Houston, A
    Coffmann, S
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (01) : 58 - 61
  • [9] Routine use of a one minute trehalase and maltase test for the identification of Candida glabrata in four laboratories
    Piens, MA
    Perry, JD
    Raberin, H
    Parant, F
    Freydière, AM
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2003, 56 (09) : 687 - 689
  • [10] Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C-albicans and C-glabrata directly from blood culture bottles
    Shepard, Janeen R.
    Addison, Rachel M.
    Alexander, Barbara D.
    Della-Latta, Phyllis
    Gherna, Michael
    Haase, Gerhard
    Hall, Gerri
    Johnson, Jennifer K.
    Merz, William G.
    Peltroche-Llacsahuanga, Heidrun
    Stender, Henrik
    Venezia, Richard A.
    Wilson, Deborah
    Procop, Gary W.
    Wu, Fann
    Fiandaca, Mark J.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (01) : 50 - 55